Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus (HIV) Prevention Projects for Community Based Organizations, PS 10-1003, Initial Review

---
identifier: "/us/fr/2010-2918"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus (HIV) Prevention Projects for Community Based Organizations, PS 10-1003, Initial Review"
title_number: 0
title_name: "Federal Register"
section_number: "2010-2918"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus (HIV) Prevention Projects for Community Based Organizations, PS 10-1003, Initial Review"
positive_law: false
currency: "2010-02-10"
last_updated: "2010-02-10"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2010-2918"
document_type: "notice"
publication_date: "2010-02-10"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "75 FR 6675"
fr_volume: 75
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus (HIV) Prevention Projects for Community Based Organizations, PS 10-1003, Initial Review

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC), announces the aforementioned meetings:

*Time and Date:*

8 a.m.-7 p.m., March 4, 2010 (Closed).

8 a.m.-7 p.m., March 5, 2010 (Closed).

*Place:* Teleconference.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the initial review, discussion, and evaluation of applications received in response to “HIV Prevention Projects for Community Based Organizations, PS10-1003.” This meeting will be subsequent to the February 7-13, 2010 meeting published in the *Federal Register* on November 19, 2010, Volume 74, Number 222, Page 59985. A second meeting is necessary due to the number of applications received and unanticipated scheduling conflicts for a significant number of the appointed reviewers.

*Contact Person for More Information:* Barbara Stewart, Deputy Director, Extramural Programs, National Center for HIV, Hepatitis and Sexually Transmitted Diseases Prevention, 1600 Clifton Road, NE., Mail Stop E-60, Atlanta, Georgia 30333, Telephone (404)498-2273, E-mail *[email protected].*

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: February 3, 2010.

Elaine L. Baker,

Director, Management Analysis and Services Office,Centers for Disease Control and Prevention.